Nilotinib hydrochloride monohydrate - analogs
Components: Nilotinib |
|||||||||
Pharmgroups: Antitumor agents - protein kinase inhibitors |
|||||||||
Prices in pharmacies: — Instructions Nilotinib hydrochloride monohydrate | |||||||||
|
ⓘ✘Enter drugs for проверки взаимодействовий through a quick button search . Convulex ✘ (incl) STS Vivadrein ✘ (incl) NFO Vitamine D3 1000 IU ✘ (incl) Ginkgo Bilobae folia ✘ (incl) Hepasol A ✘ (incl) Vitrum Junior Gummies black currant flavour ✘ (incl) Прукалоприда сукцинат ✘ (incl) Pilocarpine ✘ (incl) Pijavitum ✘ (incl) Supradyn ✘ (incl) Prolia ✘ (incl) Enalapril-Agio ✘ (incl) Гинколин+ ✘ (incl) Spasmil-M ✘ (incl) Listata ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. |
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
Similar | Complete analog ⓘ✘Аналоги препарата с полностью совпадающими действующими веществами |
Prices in pharmacies |
≈100% | Tasigna neutral | 1920€ |
≈100% | Nilotinib-nativ neutral | — |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 72% 324.5€ Иглиб Negative 🔍 [Imatinib]
- 72% — Imatinib-Alvogen Negative 🔍 [Imatinib]
- 72% — Gistamel Negative 🔍 [Imatinib]
- 72% — Imagliv Negative 🔍 [Imatinib]
- 72% — Iimatinib mesilate Negative 🔍 [Imatinib]
- 72% — Imatinib-Actavis Negative 🔍 [Imatinib]
- 72% — Imatinib medac Negative 🔍 [Imatinib]
- 72% — Citonib Negative 🔍 [Imatinib]
- 69% — Dasatinib-nativ neutral [Dasatinib]
- 69% 1388.4€ Sprycel neutral [Dasatinib]
- 65% — Дазатиниб neutral [Dasatinib]
- 65% — Дазатиниб-ТЛ neutral [Dasatinib]
- 65% 229.9-1149.4€ Bosulif neutral [Bosutinib]
- 65% — Мирсониб neutral [Dasatinib]
- 60% — Калквенс neutral [Akalabrutinib]
- 54% 271€ Neopax Negative 🔍 [Imatinib]
- 54% — Imatinib-TL Negative 🔍 [Imatinib]
- 52% — Imatinib-Teva Negative 🔍 [Imatinib]
- 52% — Цитонибонко Negative 🔍 [Imatinib]
- 52% — Imatinib Dr. Reddy s Negative 🔍 [Imatinib]
- 52% — Imvec Negative 🔍 [Imatinib]
- 52% 605€ Imatib Negative 🔍 [Imatinib]
- 52% — Imatinib Grindex Negative 🔍 [Imatinib]
- 52% — Глемихиб Negative 🔍 [Imatinib]
- 49% 798-825€ Ibrance neutral [Palbociclib]
- 49% 807.2-809.8€ Итулси neutral [Palbociclib]
- 48% — Lanvis Negative 🔍 [Tioguanine]
- 47% 73.4€ Venclexta neutral [Venetoclax]
- 46% 48.7€ Philachromin Negative 🔍 [Imatinib]
- 46% 4850€ Imbruvica neutral [Ibrutinib]
- 45% 2957.2€ Lemtrada Negative 🔍 [Alemtuzumab]
- 45% — Бозутиниб neutral [Bosutinib]
- 44% — Neitrostim neutral [Filgrastim]
- 44% 3936.6€ Кабометикс neutral [Cabozantinib]
- 44% 25.9-28.6€ Neupogen neutral [Filgrastim]
- 44% 115€ Vidaza Negative 🔍 [Azacitidine]
- 44% — Иматиниб-Сигардис Negative 🔍 [Imatinib]
- 44% — Албитиниб Negative 🔍 [Imatinib]
- 44% — Imatinib Negative 🔍 [Imatinib]
- 44% — Genfatinib Negative 🔍 [Imatinib]
- 42% 1732.5€ Lenvima neutral [Lenvatinib]
- 41% 45-106€ Рибомустин Negative 🔍 [Bendamustine]
- 41% 42.3-61€ Philachromin FS Negative 🔍 [Imatinib]
- 41% 114.4-127.7€ Glivec Negative 🔍 [Imatinib]
- 40% 14.6€ Myelastra neutral [Filgrastim]
- 39% 2417.8€ Ninlaro neutral [Ixazomib]
- 39% — Иксазомиба цитрат neutral [Ixazomib]
- 37% — Granogen neutral [Filgrastim]
- 36% 100-300€ Ацеллбия Negative 🔍 [Rituximab]
- 36% 8.3€ Puri-Nethol Negative 🔍 [Mercaptopurine]
Learn more about the selection of analogues
- The drug has «Nilotinib hydrochloride monohydrate» 3 full analogs, the cheapest - Tasigna (1920€); 51 analog by action, the most similar - Sprycel (1388.4€).
- Medical online service has selected the best substitutes for Nilotinib hydrochloride monohydrate based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of Nilotinib hydrochloride monohydrate analogues to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.